Information on this subject has been updated. Read the most recent information. Before prescribing a contraceptive, your doctor is required to discuss the options with you and to explain the risks and benefits. This will help you make a choice about which method to use. Your doctor will also need to check whether you have any risk factors that would prevent you from using an oral contraceptive 'the pill' or increase your risk of having a blood clot or other side effect. All benefits and risks need to be considered when deciding which contraceptive is best for you. The blood clots associated with using oral contraceptives occur in the veins of the legs.
Hormone Therapy and the Risk of Venous Thromboembolism
NuvaRing Blood Clots Recall Information - Stroke, DVT, Embolism And Death Compensation
Food and Drug Administration FDA is informing the public that it has not yet reached a conclusion, but remains concerned, about the potential increased risk of blood clots with the use of drospirenone-containing birth control pills. FDA has completed its review of the two studies that evaluated the risk of blood clots for women who use drospirenone-containing birth control pills, previously mentioned in FDA's Drug Safety Communication issued on May 31, FDA is continuing its review of a separate FDA-funded study that evaluated the risk of blood clots in users of several different hormonal birth control products contraceptives. Preliminary results of the FDA-funded study suggest an approximately 1. Given the conflicting nature of the findings from six published studies evaluating this risk, as well as the preliminary data from the FDA-funded study See Data Summary , FDA has scheduled a joint meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee on December 8, to discuss the risks and benefits and specifically the risk of blood clots of drospirenone-containing birth control pills. Patients should talk to their healthcare professional about their risk for blood clots before deciding which birth control pill to use.
NuvaRing Blood Clots Recall – DVT & Pulmonary Embolism Lawsuits And Compensation
Venous thromboembolism is well known as one of the rare but serious adverse effects of combined oral contraceptives COCs. The COCs with third and fourth generation progestogens were found to have higher risk of venous thrombosis than those with second generation progestogens. We present a case of pulmonary embolism in a year-old nulligravid woman who was using COCs containing the third generation progestogen desogestrel. At the time of presentation of the adverse effect, she had been using the COCs for 4 months.
Update: We are no longer accepting NuvaRing cases, but we are currently pursuing cases involving Essure side effects and Mirena complications. If you are currently using NuvaRing and have found this website looking for information about symptoms like sudden problems with vision, severe headaches, shortness of breath, bloody cough, chest pain, swelling in your legs or arms, then please get medical assistance immediately. You might be having the first signs of a blood clot. All hormonal contraceptives slightly increase the risk of blood clots, but medical studies have shown that women who use NuvaRing have a much higher risk of blood clots, stroke, deep vein thrombosis, pulmonary embolism, and even death. Deep-vein thrombosis and pulmonary embolism are both life-threatening conditions requiring immediate treatment, and a stroke can immediately cause permanent disabilities; many NuvaRing lawsuits involve patients who died as a result of the blood clot traveling to their lungs or their brain.